Short Course: October 30 | Virtual

Short Course: November 2 | Virtual

Meeting: November 7-8 | In-Person

The DIA Canada Annual Meeting will deliver a comprehensive overview of the current pharmaceutical, medical device, and/or diagnostic landscapes in Canada, while sharing insights into Canada’s broader role in global healthcare product development and is separated into three tracks: Regulatory, Clinical and Pharmacovigilance. This meeting will connect attendees with leaders and experts in academia and those involved in the regulatory, clinical, and pharmacovigilance functional areas in the pharmaceutical and medical device industry to explore best practices, lessons learned, and problem-solving strategies effecting stakeholders in Canada.

Immerse yourself in a dynamic learning experience where your career's potential knows no bounds. Discover the latest updates and priorities directly from Health Canada and supercharge your daily work with newfound knowledge. Dive into the world of artificial intelligence and machine learning, uncovering both challenges and opportunities while staying ahead of evolving regulatory expectations. Additionally, our comprehensive program covers a spectrum of vital topics, including advanced therapies, equitable drug development, the recent ICH E6 R3 revisions, what’s new and where we stand with nitrosamine impurities, data transparency, mastering Good Pharmacovigilance Practices (GVP), best practices for decentralized clinical trials, and the secrets to making swift, informed decisions. Don't miss out on this unparalleled opportunity to elevate your career to new heights!

Want to know more? View the Track Chair Video below to hear about the great content!